Researchers discover how “leaky” mitochondria can drive harmful inflammation

Plus, news about Ot­su­ka, Io­n­is, Abil­i­ty Bi­o­log­ics, San­thera, Mus­tang Bio and Vaxart: New biotech joins obe­si­ty race: Su­percede Ther­a­peu­tics raised an undis­closed seed round from

For-profit nursing schools often market their programs to people working in low-level jobs, people looking to improve their life circumstances. Many promise a flexible, expedited

An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT